General - Press Releases

Date	Title	Company
10-Jan-2022	Equillium Announces Multiple Abstracts Accepted for Presentation at the Transplantation & Cellular Meetings of ASTCT and CIBMTR	Businesswire
10-Jan-2022	Sole Source Capital Portfolio Company Peak Technologies Acquires Avalon Integration	Businesswire
10-Jan-2022	JAMP and Alvotech Announce Canadian Approval of SIMLANDI™, a High-Concentration Biosimilar to Humira®, Providing Access to Previously Unavailable Versions in Canada	Businesswire
10-Jan-2022	Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones	Businesswire
10-Jan-2022	Affini-T Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	Tenaya Therapeutics Provides 2022 Business Updates	Businesswire
10-Jan-2022	ANJAC Health & Beauty joins forces with Canadian company APOLLO to expand its North American presence	Businesswire
10-Jan-2022	ReCode Therapeutics Appoints Shehnaaz Suliman, M.D., MBA, M.Phil., as Chief Executive Officer	Businesswire
10-Jan-2022	Peptilogics Announces FDA Clearance of Investigational New Drug Application to Initiate Clinical Trial of PLG0206 in Periprosthetic Joint Infection	Businesswire
10-Jan-2022	Bluestar Genomics Appoints David Mullarkey Chief Executive Officer	Businesswire
10-Jan-2022	H3 Biomedicine Welcomes Dr. Richard Woodman to its Board of Directors	Businesswire
10-Jan-2022	Vaxiion Therapeutics Announces Clearance of IND Application for the Intralesional Administration of VAX014 to Subjects with Treatment Refractory Solid Tumors	Businesswire
10-Jan-2022	Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results	Businesswire
10-Jan-2022	NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitation	Businesswire
10-Jan-2022	Pyramid Biosciences Appoints Brian Lestini, MD, PhD as Chief Executive Officer	Businesswire
10-Jan-2022	Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	VitalConnect Announces Closure of $39 Million Round of Growth Financing	Businesswire
10-Jan-2022	Puma Biotechnology Releases Updated Corporate Presentation	Businesswire
10-Jan-2022	Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases	Businesswire
10-Jan-2022	Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates	Businesswire